These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 24434343)
1. Innovations in drug-eluting stents. Nallu K; Yang DC; Swaminathan RV; Kim LK; Feldman D Panminerva Med; 2013 Dec; 55(4):345-52. PubMed ID: 24434343 [TBL] [Abstract][Full Text] [Related]
2. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent. Waksman R; Pakala R EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674 [TBL] [Abstract][Full Text] [Related]
3. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
4. Eluting combination drugs from stents. Thipparaboina R; Khan W; Domb AJ Int J Pharm; 2013 Sep; 454(1):4-10. PubMed ID: 23850234 [TBL] [Abstract][Full Text] [Related]
5. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088 [TBL] [Abstract][Full Text] [Related]
6. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice? Byrne RA; Kastrati A EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727 [TBL] [Abstract][Full Text] [Related]
7. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable. Wiebe J; Hamm C; Nef H Catheter Cardiovasc Interv; 2015 Jun; 85(7):1184-8. PubMed ID: 25581885 [TBL] [Abstract][Full Text] [Related]
8. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial. Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234 [TBL] [Abstract][Full Text] [Related]
9. Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial. Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE EuroIntervention; 2012 May; 8(1):117-9. PubMed ID: 22580255 [TBL] [Abstract][Full Text] [Related]
10. Coronary stents: historical development, current status and future directions. Iqbal J; Gunn J; Serruys PW Br Med Bull; 2013; 106():193-211. PubMed ID: 23532779 [TBL] [Abstract][Full Text] [Related]
11. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [TBL] [Abstract][Full Text] [Related]
12. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy. Wykrzykowska JJ; Onuma Y; Serruys PW EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680 [No Abstract] [Full Text] [Related]
13. How safe and how good are drug-eluting stents? Kabir AM; Selvarajah A; Seifalian AM Future Cardiol; 2011 Mar; 7(2):251-70. PubMed ID: 21453031 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
15. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience. Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580 [TBL] [Abstract][Full Text] [Related]